Recent News
Monsanto Hit with Massive $289 Million Cancer Verdict, as First Roundup Lawsuit Trial Concludes
Monsanto has been ordered to pay $289 million to a former groundskeeper who was diagnosed with non-Hodgkin’s lymphoma following exposure to the company’s popular Roundup weed killer. The trial was the first in a nationwide litigation that currently includes more … Continue reading
Gadolinium Contrast Dye Lawsuits Could be Centralized in Single Federal Court
The growing number of lawsuits filed over Gadolinium Deposition Disease, a complication allegedly caused by certain MRI contrast dyes, could soon be consolidated in a single federal court. 20+ Gadolinium MRI Lawsuits Pending, But Plaintiffs Predict Hundreds More Will be … Continue reading
Knee Replacement Lawsuit News: Texas Man Claims DePuy Attune Knee Prone to Early Failure
A Texas man has become one of the most recent plaintiffs to file a lawsuit over DePuy Synthes’s Attune Knee System. Plaintiff Claims “Unreasonable Risk” of Attune Knee Complications was Concealed According to a complaint filed in the U.S. District … Continue reading
Ethicon Physiomesh Lawsuits Consolidated in New Jersey’s Atlantic County Superior Court
The New Jersey Supreme Court has agreed to create a Multicounty Litigation for hernia mesh lawsuits involving injuries and complications allegedly associated with Ethicon, Inc.’s Physiomesh Flexible Composite mesh implants. According to a Notice issued on August 15th, all such claims … Continue reading
Court Overseeing Federal Testosterone Lawsuits Reports Finalization of Androderm Settlement
The federal court overseeing thousands of testosterone treatment lawsuits reported last month that the manufacturer of Androderm has finalized a settlement with more than 500 men who claim their use of the medication caused heart attacks, blood clots, and other … Continue reading
South Korea Bans Certain Gadolinium MRI Contrast Dyes Amid Safety Concerns
As gadolinium MRI contrast dye lawsuits continue to mount in courts throughout the United States, concerns that the drugs might accumulate in the brain have prompted health regulators in South Korea to announce a temporary ban on linear gadolinium agents. … Continue reading
Court Overseeing Federal Proton Pump Inhibitor Lawsuits Establishes Protocols for Defendant Fact Sheets
Nexium lawsuits and other kidney injury claims involving a class of heart burn drugs called proton pump inhibitors continue to move forward in a multidistrict litigation now underway in the U.S. District Court, District of New Jersey. On July 30th, … Continue reading
Parties to Atrium C-Qur Hernia Mesh Lawsuits Select Bellwether Trial Candidates
The federal litigation involving hundreds of hernia mesh lawsuits filed on behalf of individuals allegedly injured by Atrium Medical’s C-Qur devices continues to prepare for bellwether trials. According to a Joint Notice filed in the U.S. District Court, District of … Continue reading
Onglyza Lawsuit Claims AstraZeneca Hid Saxagliptin Heart Failure Risks
A plaintiff from Georgia has filed a new Onglyza lawsuit that accuses AstraZeneca of concealing the potential for heart failure and other side effects allegedly associated with saxagliptin, the active ingredient in the Type 2 diabetes medication. Plaintiff Would Not … Continue reading
Additional Manufacturer Added to Valsartan Heart Drug Recall
The U.S. Food & Drug Administration (FDA) has added tablets marketed by another manufacturer to the massive valsartan recall for blood pressure and heart medications that may contain a cancer-causing chemical. Camber Pharmaceuticals Valsartan Recall The recall expansion was announced … Continue reading
Follow Us
